 |
| |
 | |
Glossary
|
- 3TC
- lamivudine
- AZT
- zidovudine(also ZDV)
- bid
- twice daily
- CDC
- Centers for Disease Control and Prevention
- DKA
- diabetic ketoacidosis
- DNA
- deoxyribonucleic acid
- FDA
- Food and Drug Administration
- GC
- gonococcus
- GHB
- γ hydroxy butyrate
- HAART
- highly active antiretroviral therapy
- HBIg
- hepatitis B immunoglobulin
- β-HCG
- human chorionic gonadotropin β subunit
- HIV
- human immunodeficiency virus
- im
- intramuscular
- IUD
- intrauterine device
- OB/GYN
- obstetrician/gynocologist
- OCP
- oral contraceptive pill
- PID
- pelvic inflammatory disease
- po
- orally
- PTSD
- posttraumatic stress disorder
- qid
- four times daily
- RPR
- rapid plasma reagin
- STD
- sexually transmitted disease
- tid
- three times daily
- VDRL
- Venereal Disease Research Laboratory (test)
|
|
|
| Carolyn J. Sachs, MD, MPH has no financial relationships with pharmaceutical companies, biomedical device manufacturers, or health-care related organizations.
Steven E. Weinberger, MD, FACP, Acting Editor, PIER, has stock holdings in Glaxosmithkline and Abbott. |
|
|
|
The information included herein should never be used as a substitute
for clinical judgment and does not represent an official position of
ACP. Because all PIER modules are updated regularly, printed web pages
or PDFs may rapidly become obsolete. Therefore, PIER users should
compare the date of the last update on the website with any printout
to ensure that the information being referred to is the most current
available.
|
PIER is copyrighted (c) 2009 by the American College of Physicians,
190 N. Independence Mall West, Philadelphia, PA 19106-1572, USA.
|
|
|
Sexual Assault